Genexa
PrivateLast Round
Series A
Jul 14, 2021
Est. Valuation
$200M
Total Funding Raised
$60.5M
Company Overview
Genexa operates in Healthcare & Life Sciences and is based in Atlanta, Georgia. Its latest recorded funding round was a Series A round in July 2021.
Genexa is a pharmaceutical company that develops and markets clean over-the-counter medicines using effective active ingredients without artificial inactive ingredients.
Sector
Healthcare & Life Sciences
Verticals
D2C Brands, Home & Lifestyle, E-commerce
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genexa Comparables
Compare Genexa with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| KinderFarms | 82% | |
| EEZ Co. | 81% | |
| Hyland's Naturals | 79% |
For institutional investors. Book with your work email.
Genexa Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 14, 2021 | ||||
| Growth Equity | Nov 20, 2018 | ||||
| Convertible Debt | Nov 20, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Genexa Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Platinum Mile Ventures | Series A |
| Verlinvest | Series A |
| North Castle Partners | Series A |
| Monogram Capital Partners | Series A |
| Point King Capital | Series A |
| Unilever Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 14, 2021
$60M round led by Monogram Capital Partners.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withSep 15, 2026
On Sep 15th '26 in Georgia, Genexa Inc. is working with Good Inside to offer 100 memberships that support parents in the earliest days of parenthood.
For institutional investors. Book with your work email.
Genexa Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Genexa's valuation, stock price, and market status.
Is Genexa a public or private company?
Genexa is a private company.
What is the current stock price of Genexa?
Genexa is a private company, so its shares have no public market price. Caplight tracks Genexa's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Genexa worth (valuation)?
Genexa's valuation is estimated at $200.0M based on funding round data.
Can I buy Genexa stock?
Genexa shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Genexa's last funding round?
Genexa's most recent funding round was Series A on July 14, 2021.
Who are the main investors in Genexa?
Key investors in Genexa include Monogram Capital Partners.
Will Genexa IPO soon?
No public IPO plans have been announced for Genexa.
How can I track Genexa secondary market activity?
Caplight tracks bids, offers, and trades in Genexa's shares on secondary markets.